Skip to content

ACECARDIO

Active Private limited companyfounded 2019active for 7 yearsAvenue de la Rose des Vents 10, 1410 WaterlooKBO/BCE: BE 0730.664.673

Lifetime

6 annual accounts with figures on one time axis
peak of €195,798 in 2025
€195,798▲ 14.9%
peak of €135,468 in 2025
€135,468▲ 15.9%
peak of €220,161 in 2022
€137,943▲ 12.6%
€392,337▲ 3.9%
Documentsfilings and deeds
26-08-202626 days late
2025micro format
Gross margin from €170,387 to €195,798Dividend €120,000Equity from €122,475 to €137,943

Key points

from the 2025 annual accounts

Equity

€137,943 ▲ 12.6%
122,4752024+135,468Profit-120,000Dividend137,9432025

ACECARDIO paid out €120,000 in dividends. That is 89% of the 2025 profit.

Debts

€392,337 74% of the balance sheet
Financial debts 48%Suppliers 1%Taxes and wages 6%Other 45%

Of this, €202,019 falls due within a year.

Filings

6 annual accounts 6 late
AprilJune31 JulyOctober202020222024

The 2020 accounts came in latest, 200 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,684 companies had the same profile as ACECARDIO has now. Each dot stands for 7 companies, two years later.

97.2%
were still trading
1.3%
stopped another way
1.3%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,684 companies, not a prediction for ACECARDIO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Director, last mentioned in 2019
  • 100 sharesdeed of 16-07-2019
Board & ownership

Recent changes

Company renamed from ALISSON SLIMANI CARDIOLOGIE to ACECARDIO General meeting of 24-08-2022 · Gazette deed
Registered office moved from Braine-l'Alleud to Waterloo The registered office moved from Rue César Franck 4, 1420 Braine-l'Alleud to Avenue de la Rose des Vents. 10, 1410 Waterloo · Board meeting of 01-07-2021 · Gazette deed
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 16-07-2019 · Gazette deed
All 13 events

Official details

Source: KBO
Status
Active since 12-07-2019Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unit
Establishment unit
2.291.466.4341420 Braine-l'Alleud, since 12-07-2019
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €480,000estimated
€530,280▲ 6.1%
Filing
Filed on 26-08-2026
Financials

Insights on ACECARDIO

ACECARDIO files the micro format. That format states no turnover. The gross margin rose from €89,241 in 2020 to €195,798 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ACECARDIO

What is the company number of ACECARDIO?
The company number of ACECARDIO is 0730.664.673. The VAT number is the same number with BE in front: BE 0730.664.673.
Where is ACECARDIO based?
The registered office is at Avenue de la Rose des Vents 10, 1410 Waterloo.Company details
What does ACECARDIO do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of ACECARDIO?
ACECARDIO is a private limited company (BV).
When was ACECARDIO founded?
ACECARDIO was founded on 12-07-2019.
Is ACECARDIO still active?
Yes, ACECARDIO is an active enterprise in the KBO register.
What is the turnover of ACECARDIO?
The turnover in financial year 2025 is about €480,000. This figure is estimated from the gross margin of €195,798 and 2,452 comparable companies of the same size. It probably lies between €320,000 and €750,000. It is a rough estimate.Financials
Is ACECARDIO profitable?
In financial year 2025, ACECARDIO made a profit of €135,468.
Where can I find the annual accounts of ACECARDIO?
ACECARDIO filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ACECARDIO due?
ACECARDIO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.